First U.S. Use of VitaSmart™ HOPE System Signals Early Confidence

First U.S. Use of VitaSmart™ HOPE System Signals Early Confidence

Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®

Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®

Regulus Therapeutics Progresses to Cohort 4 in Phase 1b MAD Trial of RGLS8429 for ADPKD Treatment

Regulus Therapeutics Progresses to Cohort 4 in Phase 1b MAD Trial of RGLS8429 for ADPKD Treatment

Agomab Receives FDA Orphan Drug Designation for AGMB-447 in Idiopathic Pulmonary Fibrosis

Agomab Receives FDA Orphan Drug Designation for AGMB-447 in Idiopathic Pulmonary Fibrosis

ZERO Prostate Cancer responds to the devastating 57% cut in lifesaving medical research programs

ZERO Prostate Cancer responds to the devastating 57% cut in lifesaving medical research programs

Acclaro Medical to Showcase 11 Podium Presentations Highlighting the UltraClear® 2910 nm Fiber Laser

Acclaro Medical to Showcase 11 Podium Presentations Highlighting the UltraClear® 2910 nm Fiber Laser

Featured Press Releases

Sutter Health Expands Wearable Ultrasound Technology to More Bay Area Hospitals for Sepsis Care

Sutter Health Expands Wearable Ultrasound Technology to More Bay Area Hospitals for Sepsis Care

Sarasota Memorial Cancer Team Expands Detection, Achieves 75% Early-Stage Lung Cancer Diagnosis Rate

Sarasota Memorial Cancer Team Expands Detection, Achieves 75% Early-Stage Lung Cancer Diagnosis Rate

  • 13 Apr 2026

Sarasota Memorial Health Care System (SMH) reported that 75% of lung cancers diagnosed through an...

At-Home GLP-1 Monitoring Panels for Ozempic, Wegovy, and Mounjaro Users Launched by Choose Health

At-Home GLP-1 Monitoring Panels for Ozempic, Wegovy, and Mounjaro Users Launched by Choose Health

Early Pregnancy Detection Advances with Cell-Free DNA Technology by Zymo Research and STORI

Early Pregnancy Detection Advances with Cell-Free DNA Technology by Zymo Research and STORI

Eric Khairy Appointed as Chief Marketing Officer at Cytovale

Eric Khairy Appointed as Chief Marketing Officer at Cytovale

Now Available in Canada: Lenire Tinnitus Treatment Device

Now Available in Canada: Lenire Tinnitus Treatment Device

Sutter Health Expands Wearable Ultrasound Technology to More Bay Area Hospitals for Sepsis Care

Sutter Health Expands Wearable Ultrasound Technology to More Bay Area Hospitals for Sepsis Care

  • Flosonics Medical
  • 14 Apr 2026
Sarasota Memorial Cancer Team Expands Detection, Achieves 75% Early-Stage Lung Cancer Diagnosis Rate

Sarasota Memorial Cancer Team Expands Detection, Achieves 75% Early-Stage Lung Cancer Diagnosis Rate

  • Sarasota Memorial Health Care System
  • 13 Apr 2026
At-Home GLP-1 Monitoring Panels for Ozempic, Wegovy, and Mounjaro Users Launched by Choose Health

At-Home GLP-1 Monitoring Panels for Ozempic, Wegovy, and Mounjaro Users Launched by Choose Health

  • Choose Health
  • 09 Apr 2026
Early Pregnancy Detection Advances with Cell-Free DNA Technology by Zymo Research and STORI

Early Pregnancy Detection Advances with Cell-Free DNA Technology by Zymo Research and STORI

  • Zymo Research Corp.
  • 09 Apr 2026
Eric Khairy Appointed as Chief Marketing Officer at Cytovale

Eric Khairy Appointed as Chief Marketing Officer at Cytovale

  • Cytovale
  • 07 Apr 2026
Now Available in Canada: Lenire Tinnitus Treatment Device

Now Available in Canada: Lenire Tinnitus Treatment Device

  • Neuromod Devices
  • 07 Apr 2026
Int'l Conference on Digital Healthcare New York 2026
Promotional banner inviting healthcare & medical companies to feature their press releases on Healthcare-Era.com, highlighting outreach to over 380K healthcare industry professionals, 4.5K+ digital media outlets, and 18K+ journalists and bloggers.

Most Popular
April   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

User Area

Discover

Engage with Us

© Healthcare Era — A product of HISSM. All Rights Reserved.